Bexsero-Meningitis Group B
£115.00
2 in stock
Description
Bexsero is a vaccine used to protect against meningococcal group B (MenB) disease. It is a multicomponent vaccine, meaning it contains multiple components that work together to provide protection against MenB.
How does it work? Bexsero works by introducing small, harmless pieces of the meningococcal bacteria to the body, which triggers the immune system to produce antibodies. These antibodies help to protect against future infections caused by Neisseria meningitidis serogroup B.
Who is it for? Bexsero is administered to individuals from 2 months to 18 years of age to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B.
How is it administered? The vaccine is given as a series of injections, typically 2-3 doses, depending on the age of the individual and the country’s vaccination schedule.
Efficacy Bexsero has been shown to be effective in preventing invasive meningococcal disease caused by MenB. Studies have demonstrated that the vaccine provides protection against a range of MenB strains.
Side effects Common side effects of Bexsero include pain, redness, and swelling at the injection site, as well as fever, headache, and fatigue. These side effects are usually mild and temporary.
Contraindications Bexsero is contraindicated in individuals with a history of anaphylaxis to any component of the vaccine, as well as those with a weakened immune system.
